Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage

Current — Oryza Pharmaceuticals Inc.

The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from Oryza Pharmaceuticals Inc. with status Current. The shortage was first posted on Oct 12, 2022. Reported reason: Shortage of an active ingredient

Shortage details

Status
Current
Company
Oryza Pharmaceuticals Inc.
Package NDC
72516-014-01
Dosage Form
Tablet
Presentation
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)
Initial Posting
Oct 12, 2022

Reason

Shortage of an active ingredient

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.